United Kingdom renal denervation market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to growing instances of hypertension. Growing complexities of the hypertension disorders and its adverse effect on the kidney functioning drives the growth of the United Kingdom renal denervation market in the upcoming five years. Growing advancement in the medical devices supportive of the renal denervation procedure also fuel the growth of the United Kingdom renal denervation market in the next five years.

Renal denervation (RDN) is a minimally invasive procedure to treat therapeutic resistant hypertension. Under the circumstances where hypertension conditions do not respond to aggressive medical treatment that may arise due to either patient taking different blood pressure medications at the highest capacity of the drugs or if the medication is diuretic that means it removes the fluids and salt from the body that is hindering with the renal functions. The procedure uses radiofrequency ablation to burn the nerves in the renal arteries. This process causes a reduction in the nerve activity, which decreases blood pressure.

Surging Number of Hypertension Patients Promises Market Growth

Rapidly increasing number of patients suffering from the hypertension and high blood pressure drive the growth of the United Kingdom renal denervation market in the upcoming five years. Prolonged food habits, sedentary lifestyle, and growing consumption of alcohol and smoking instances enhance the risks of hypertension and high blood pressure as well as disturbing the normal kidney functions too, thereby facilitating the growth of the United Kingdom renal denervation market in the next five years.

High blood pressure affects more than 1 in 4 adults in England, around 12.5 million people in 2015. The prevalence of high blood pressure for adults in England in 2015 was 31% among men and 26% among women, with little change over the last few years. Furthermore, technologically advanced equipment and medical devices flooding the healthcare industry in the country also substantiate the growth of the United Kingdom renal denervation market in the future five years.


Click here to download the sample

Market Segmentation

The United Kingdom renal denervation market is segmented by technology, product, therapeutic area, end user, competitional landscape, and regional distribution. Based on technology, the market is further segmented into ultrasound ablation, radiofrequency ablation, pharmacologic ablation, and micro-infusion. By product, the market is fragmented into catheters, single electrode catheter, multi electrode catheter, RF generator, and others. Based on therapeutic area, the market is differentiated into hypertension, heart failure, diabetes, renal failure, and others. By end user, the market is further bifurcated into hospitals & clinics, ambulatory care centers, and other. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.

Company Profile

Medtronic United Kingdom, Boston Scientific Limited, Abbott Laboratories Limited, CardioSonic Limited, Terumo UK Limited, Johnson & Johnson Limited, among others is a partial list of major market players of the companies responsible for the growth of United Kingdom renal denervation market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Technology

·         Product

·         Therapeutic Area

·         End User

Regional scope

London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside

Key companies profiled

Medtronic United Kingdom, Boston Scientific Limited, Abbott Laboratories Limited, CardioSonic Limited, Terumo UK Limited, Johnson & Johnson Limited

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United Kingdom renal denervation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United Kingdom Renal Denervation Market, By Technology:
    • Ultrasound Ablation
    • Radiofrequency Ablation
    • Pharmacologic Ablation
    • Micro-infusion
  • United Kingdom Renal Denervation Market, By Product:
    • Catheters
    • Single Electrode Catheter
    • Multi Electrode Catheter
    • RF Generator
    • Others
  • United Kingdom Renal Denervation Market, By Therapeutic Area:
    • Hypertension
    • Heart Failure
    • Diabetes
    • Renal Failure
    • Others
  • United Kingdom Renal Degeneration Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Care Centers
    • Others
  • United Kingdom Renal Denervation Market, By Region:

o   London

o   East Anglia

o   Southwest

o   Southeast

o   Scotland

o   East Midlands

o   Yorkshire & Humberside

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom renal denervation market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

United Kingdom Renal Denervation Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Renal Denervation Market

4.    Executive Summary

5.    Voice of Customer

6.    United Kingdom Renal Denervation Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion)

6.2.2.     By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others)

6.2.3.     By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others)

6.2.4.     By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    London Renal Denervation Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Technology

7.2.2.     By Product

7.2.3.     By Therapeutic Area

7.2.4.     By End User

8.    East Anglia Renal Denervation Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Technology

8.2.2.     By Product

8.2.3.     By Therapeutic Area

8.2.4.     By End User

9.    Southwest Renal Denervation Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Technology

9.2.2.     By Product

9.2.3.     By Therapeutic Area

9.2.4.     By End User

10.  Southeast Renal Denervation Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Technology

10.2.2.  By Product

10.2.3.  By Therapeutic Area

10.2.4.  By End User

11.  Scotland Renal Denervation Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Technology

11.2.2.  By Product

11.2.3.  By Therapeutic Area

11.2.4.  By End User

12.  East Midlands Renal Denervation Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Technology

12.2.2.  By Product

12.2.3.  By Therapeutic Area

12.2.4.  By End User

13.  Yorkshire & Humberside Renal Denervation Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Technology

13.2.2.  By Product

13.2.3.  By Therapeutic Area

13.2.4.  By End User

14.  Market Dynamics

14.1.              Drivers

14.2.              Challenges

15.  Market Trends & Developments

16.  Policy & Regulatory Landscape

17.  United Kingdom Economic Profile

18.  Competitive Landscape

18.1.              Medtronic United Kingdom

18.2.              Boston Scientific Limited

18.3.              Abbott Laboratories Limited

18.4.              CardioSonic Limited

18.5.              Terumo UK Limited

18.6.              Johnson & Johnson Limited

19. Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com